These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 8172913)

  • 1. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride.
    Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
    Biochim Biophys Acta; 1994 May; 1191(2):278-90. PubMed ID: 8172913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
    Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.
    Müller G; Hartz D; Pünter J; Okonomopulos R; Kramer W
    Biochim Biophys Acta; 1994 May; 1191(2):267-77. PubMed ID: 8172912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
    Kramer W; Müller G; Geisen K
    Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct photoaffinity labeling of the putative sulfonylurea receptor in rat beta-cell tumor membranes by [3H]glibenclamide.
    Kramer W; Oekonomopulos R; Pünter J; Summ HD
    FEBS Lett; 1988 Mar; 229(2):355-9. PubMed ID: 2831099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photoaffinity labeling of the cerebral sulfonylurea receptor using a novel radioiodinated azidoglibenclamide analogue.
    Schwanstecher M; Löser S; Chudziak F; Bachmann C; Panten U
    J Neurochem; 1994 Aug; 63(2):698-708. PubMed ID: 8035194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mitochondrial sulfonylurea receptor: identification and characterization.
    Szewczyk A; Wójcik G; Lobanov NA; Nałecz MJ
    Biochem Biophys Res Commun; 1997 Jan; 230(3):611-5. PubMed ID: 9015372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a 65 kDa sulfonylurea receptor in rat pancreatic zymogen granule membranes.
    Braun M; Anderie I; Thévenod F
    FEBS Lett; 1997 Jul; 411(2-3):255-9. PubMed ID: 9271216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein inhibition by glibenclamide and related compounds.
    Golstein PE; Boom A; van Geffel J; Jacobs P; Masereel B; Beauwens R
    Pflugers Arch; 1999 Apr; 437(5):652-60. PubMed ID: 10087141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and solubilization of the sulphonylurea receptor in rat brain.
    Niki I; Ashcroft SJ
    Neuropharmacology; 1993 Oct; 32(10):951-7. PubMed ID: 8295717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of sulfonylurea receptors in isolated human pancreatic islets.
    Giannaccini G; Lupi R; Trincavelli ML; Navalesi R; Betti L; Marchetti P; Lucacchini A; Del Guerra S; Martini C
    J Cell Biochem; 1998 Nov; 71(2):182-8. PubMed ID: 9779817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
    Hambrock A; Löffler-Walz C; Russ U; Lange U; Quast U
    Mol Pharmacol; 2001 Jul; 60(1):190-9. PubMed ID: 11408614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide.
    Hu S; Wang S; Fanelli B; Bell PA; Dunning BE; Geisse S; Schmitz R; Boettcher BR
    J Pharmacol Exp Ther; 2000 May; 293(2):444-52. PubMed ID: 10773014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the sulfonylurea receptor on beta cell membranes.
    Gaines KL; Hamilton S; Boyd AE
    J Biol Chem; 1988 Feb; 263(6):2589-92. PubMed ID: 3125168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photoaffinity labeling and partial purification of the beta cell sulfonylurea receptor using a novel, biologically active glyburide analog.
    Aguilar-Bryan L; Nelson DA; Vu QA; Humphrey MB; Boyd AE
    J Biol Chem; 1990 May; 265(14):8218-24. PubMed ID: 2110566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
    Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
    J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta.
    Löffler C; Quast U
    Br J Pharmacol; 1997 Feb; 120(3):476-80. PubMed ID: 9031752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular K(ATP) channels.
    Stephan D; Winkler M; Kühner P; Russ U; Quast U
    Diabetologia; 2006 Sep; 49(9):2039-48. PubMed ID: 16865362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cooperative binding of ATP and MgADP in the sulfonylurea receptor is modulated by glibenclamide.
    Ueda K; Komine J; Matsuo M; Seino S; Amachi T
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1268-72. PubMed ID: 9990013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
    Schwanstecher M; Mnner K; Panten U
    Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.